StockWatch
·
Medical Equipment & Supplies
Regulatory13 Aug 2026, 05:33 pm

Shree Pacetronix Ltd: No Deviation in Preferential Issue Fund Use

AI Summary

Shree Pacetronix Ltd has filed a statement confirming no deviation or variation in the utilization of funds raised through a Preferential Issue for the quarter ended June 30, 2026. The statement, reviewed by the Audit Committee and taken on record by the Board, pertains to funds raised via allotment of equity shares and warrants on a preferential basis on November 14, 2025, and conversion of warrants on March 20, 2026. The total amount raised was ₹243.48 Lakhs. The company reported nil deviation in the utilization of funds for capital expenditure and general corporate purposes for the specified quarter.

Key Highlights

  • No deviation reported in preferential issue fund utilization for Q2 FY27.
  • Funds raised via equity shares and warrants on November 14, 2025.
  • Total funds raised amounted to ₹243.48 Lakhs.
  • Statement reviewed by Audit Committee and Board.
  • No deviation in capital expenditure or general corporate purposes.